AstraZeneca says early trial data indicates third dose helps

Advertise with us

Advertise with us

Health & Wellbeing

AstraZeneca

AstraZeneca says early trial data indicates third dose helps against Omicron

AstraZeneca (AZN.L) said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against the Omicron and other variants when given as a third booster dose. The increased response..
AstraZeneca vaccine booster works against Omicron, Oxford lab study finds

A three-dose course of AstraZeneca's (AZN.L) COVID-19 vaccine is effective against the rapidly-spreading Omicron coronavirus variant, the pharmaceutical company said on Thursday, citing data from an Oxford University lab study. Findings from t..
AstraZeneca, Oxford aim to produce Omicron-targeted vaccine

AstraZeneca Plc (AZN.L) said on Tuesday it is working with Oxford University to produce a vaccine for the Omicron coronavirus variant, joining other vaccine-makers who are looking to develop the variant-specific vaccine. "Together with Oxford..
Trigger of rare blood clots with AstraZeneca jab found by scientists

Scientists believe they have found "the trigger" that leads to extremely rare blood clots after the Oxford-AstraZeneca Covid vaccine. The team - in Cardiff and the US - have shown in exquisite detail how a protein in the blood is attract..
AstraZeneca-Oxford COVID-19 vaccine supply hits two billion doses

Two billion doses of the AstraZeneca-Oxford University COVID-19 vaccine have been supplied worldwide, the Anglo-Swedish drugmaker and its partner said on Tuesday, in just under a year since its first approval. The shot, which is the biggest contri..
EU says people vaccinated with AstraZeneca shots should be able to travel to U.S.

The European Commission said on Tuesday it would make sense for the United States to allow travel by people vaccinated with the AstraZeneca (AZN.L) COVID-19 shots, although existing U.S. guidance already authorises those travellers. On M..
EU lists rare nerve disorder as possible side-effect of AstraZeneca COVID-19 vaccine

REUTERS Europe's medicines regulator has added an extremely rare nerve-damaging disorder, Guillain-Barré syndrome, as a possible side-effect of AstraZeneca's (AZN.L) COVID-19...
AstraZeneca's antibody therapy prevents COVID-19, study shows

REUTERS Trial data from AstraZeneca (AZN.L) on Friday raised the prospect of a new treatment to prevent COVID-19 beyond vaccines, giving hope in particular for people who respond poorly to ...
AstraZeneca Second Dose Doesn't Raise Risk of Rare Blood Clots

REUTERS AstraZeneca's COVID-19 vaccine carries a small extra risk of rare blood clots with low platelets after the first dose and no extra risk after the second, a study led and funded by the drugmaker showed on Wednesday, after worries over s..

Desert Falls Live a Little — VIDEO OF THE WEEK

Follow US

categories